Armin Zebisch

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

Leukemia

International journal of molecular sciences

Biomedicines

Annals of hematology

Medical University of Graz

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Graz

Austria

Associate Professor :: Division of Hematology & Otto-Loewi Research Center

Publications

Jennifer Moritz, Antonia Schwab, Andreas Reinisch, Armin Zebisch, Heinz Sill, Albert Wölfler
Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions. Biomedicines 12 (3) (2024)
Jennifer Moritz, Antonia Schwab, Andreas Reinisch, Armin Zebisch, Heinz Sill, Albert Wölfler
Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions. Biomedicines 12 (3) (2024)
Johannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia, Angelika Schlacher, Lisa Auinger, Karl Kashofer, Christine Beham-Schmid, Slave Trajanoski, Claudia Waskow, Wolfgang Schöll, Heinz Sill, Armin Zebisch, Albert Wölfler, Daniel Thomas, Andreas Reinisch
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities. Leukemia (2023)
Johannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia, Angelika Schlacher, Lisa Auinger, Karl Kashofer, Christine Beham-Schmid, Slave Trajanoski, Claudia Waskow, Wolfgang Schöll, Heinz Sill, Armin Zebisch, Albert Wölfler, Daniel Thomas, Andreas Reinisch
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities. Leukemia (2023)
Tommaso Sconocchia, Johannes Foßelteder, Lisa Auinger, Erdem Özkaya, Theresa Benezeder, Magdalena Lang, Christine Beham-Schmid, Gerald Hoefler, Armin Zebisch, Albert Wölfler, Heinz Sill, Peter Wolf, Herbert Strobl, Andreas Reinisch
BRAF V600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis. Leukemia (2023)
Michael Leisch, Michael Pfeilstöcker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Christoph Tinchon, Bernd Hartmann, Andreas Petzer, Martin Schreder, David Kiesl, Sonia Vallet, Alexander Egle, Thomas Melchardt, Gudrun Piringer, Armin Zebisch, Sigrid Machherndl-Spandl, Dominik Wolf, Felix Keil, Manuel Drost, Richard Greil, Lisa Pleyer
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group. Cancers 14 (10) (2022)
Armin Zebisch, Heinz Sill
How do non-coding RNAs impact treatment regimens currently being used in AML? Expert review of anticancer therapy 22 (4) (2022)
Johannes Lorenz Berg, Bianca Perfler, Stefan Hatzl, Marie-Christina Mayer, Sonja Wurm, Barbara Uhl, Andreas Reinisch, Ingeborg Klymiuk, Sascha Tierling, Gudrun Pregartner, Gerhard Bachmaier, Andrea Berghold, Klaus Geissler, Martin Pichler, Gerald Hoefler, Herbert Strobl, Albert Wölfler, Heinz Sill, Armin Zebisch
Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia. Clinical epigenetics 13 (1) (2021)
Marie-Christina Mayer, Johannes Lorenz Berg, Bianca Perfler, Stefan Hatzl, Sereina Annik Herzog, Gerhard Bachmaier, Andrea Berghold, Andreas Reinisch, Albert Wölfler, Heinz Sill, Armin Zebisch
miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms. Annals of hematology 100 (11) (2021)
Johannes Lorenz Berg, Bianca Perfler, Stefan Hatzl, Barbara Uhl, Andreas Reinisch, Gudrun Pregartner, Andrea Berghold, Thomas Penz, Michael K Schuster, Klaus Geissler, Andreas Prokesch, Carsten Muller-Tidow, Gerald Hoefler, Karl Kashofer, Albert Wölfler, Heinz Sill, Veronica Caraffini, Armin Zebisch
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity. Leukemia 35 (5) (2021)
Klaus Geissler, Eva Jäger, Agnes Barna, Michael Gurbisz, Temeida Graf, Elmir Graf, Thomas Nösslinger, Michael Pfeilstöcker, Heinz Tüchler, Thamer Sliwa, Felix Keil, Christoph Geissler, Sonja Heibl, Josef Thaler, Sigrid Machherndl-Spandl, Otto Zach, Ansgar Weltermann, Peter Bettelheim, Reinhard Stauder, Armin Zebisch, Heinz Sill, Ilse Schwarzinger, Bruno Schneeweiss, Leopold Öhler, Ernst Ulsperger, Rajko Kusec, Ulrich Germing, Wolfgang R Sperr, Paul Knöbl, Ulrich Jäger, Gregor Hörmann, Peter Valent
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients. International journal of molecular sciences 21 (8) (2020)
Klaus Geissler, Eva Jäger, Agnes Barna, Michael Gurbisz, Temeida Graf, Elmir Graf, Thomas Nösslinger, Michael Pfeilstöcker, Sigrid Machherndl-Spandl, Reinhard Stauder, Armin Zebisch, Heinz Sill, Leopold Öhler, Rajko Kusec, Gregor Hörmann, Peter Valent
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia. International journal of molecular sciences 21 (17) (2020)
Gabriel Pabst, Karin Lind, Ricarda Graf, Armin Zebisch, Friedrich Stölzel, Konstanze Döhner, Ellen Heitzer, Andreas Reinisch, Heinz Sill
TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model. Annals of hematology 99 (3) (2020)
Subramanian Anirudh, Angelika Rosenberger, Elke Schwarzenberger, Carolin Schaefer, Herbert Strobl, Armin Zebisch, Heinz Sill, Albert Wölfler
TNFα Rescues Dendritic Cell Development in Hematopoietic Stem and Progenitor Cells Lacking C/EBPα. Cells 9 (5) (2020)
Peter Ulz, Samantha O Perakis, Qing Zhou, Tina Moser, Jelena Belic, Isaac Lazzeri, Albert Wölfler, Armin Zebisch, Armin Gerger, Gunda Pristauz, Edgar Petru, Brandon White, Charles E S Roberts, John St John, Michael G Schimek, Jochen B Geigl, Thomas Bauernhofer, Heinz Sill, Christoph Bock, Ellen Heitzer, Michael R Speicher
Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection. Nature communications 11 (1) (2020)
Sayantanee Dutta, Gudrun Pregartner, Frank G Rücker, Ellen Heitzer, Armin Zebisch, Lars Bullinger, Andrea Berghold, Konstanze Döhner, Heinz Sill
Functional Classification of TP53 Mutations in Acute Myeloid Leukemia. Cancers 12 (3) (2020)
Peter Ulz, Samantha O Perakis, Qing Zhou, Tina Moser, Jelena Belic, Isaac Lazzeri, Albert Wölfler, Armin Zebisch, Armin Gerger, Gunda Pristauz, Edgar Petru, Brandon White, Charles E S Roberts, John St John, Michael G Schimek, Jochen B Geigl, Thomas Bauernhofer, Heinz Sill, Christoph Bock, Ellen Heitzer, Michael R Speicher
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection. Nature communications 10 (1) (2019)
Armin Zebisch, Gerlinde Winter, Karl Kashofer, Stefan Hatzl, Barbara Uhl, Sonja Wurm, Albert Wölfler, Hildegard T Greinix, Gerald Hoefler, Heinz Sill
The role of germline mutation profiling in the selection of related donors for haematopoietic stem cell transplantation. Bone marrow transplantation 55 (7) (2019)
Armin Zebisch, Veronica Caraffini, Heinz Sill
RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis. International journal of molecular sciences 20 (22) (2019)

Armin Zebisch.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Armin Zebisch